AI is poised to revolutionise healthcare. Building trust will be key.

OECD

Artificial intelligence played a pivotal role during the COVID-19 pandemic, from hastening diagnoses to supporting contract tracing and more. In this sense, the pandemic has already shown us how A.I. can benefit healthcare. But this seems just the beginning of revolution. What else can be done? What are the limits and risks of using artificial intelligence in health care? And how can we best ensure that it is both effective and trustworthy? We’ll answer these questions with Lina Gálvez Muñoz, MEP from Spain, Vice Chair of the Committee on Industry, Research and Energy, member of the European Parliament’s Panel for the Future of Science and Technology (STOA) and of the OECD Parliamentary Group on AI; and Karim Lekadir, head of EUCanImage, a four year AI research project aimed at making advances in oncology which has 20 partners across 11 countries. This podcast is first in a series in 2022 on Artificial intelligence, brought to you by the OECD’s Global Parliamentary Network and the European Parliament’s Panel for the Future of Science and Technology, also known as STOA. Guests: Lina Gálvez-Muñoz, Karim Lekadir Host: Robin Allison Davis Producer: Samia Basille To learn more about EUCanImage go to their website, EUCanImage.eu. To learn more about the EU Parliament’s Panel for the Future of Science and Technology’s work on AI, go to: https://www.europarl.europa.eu/stoa/en/home/highlights To learn more about the OECD Global Parliamentary Network, go to: https://www.oecd.org/parliamentarians/ To learn more about the OECD’s work on AI, go to: oecd.ai